Program By Day

7:00 AM-7:55 AM Rapid Fire Abstract Session: Cancers of the Colon, Rectum, and Anus
7:00 AM-7:55 AM Poster Session C: Cancers of the Colon, Rectum, and Anus
7:00 AM-7:55 AM Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus
7:00 AM-7:55 AM Breakout Session: Intraperitoneal Chemotherapy for Intra-abdominal Malignancies

TBD
Debate: Role of Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer

Edward Allen Levine, MD
Wake Forest University, School of Medicine
Pro

Garrett Michael Nash, MD
Memorial Sloan Kettering Cancer Center
Con

Steven Arthur Ahrendt, MD
University of Colorado, School of Medicine
Appendiceal Tumors and Peritoneal Mesotheliomas

Panel Question and Answer
7:00 AM-7:55 AM Breakout Session: Liquid Biopsies—Role in Management of Gastrointestinal Cancers

TBD
Overview of Technology: Circulating Tumor Cells and DNA

Ryan Bruce Corcoran, MD, PhD
Massachusetts General Hospital
Clinical Implications of Liquid Biopsies

Panel Question and Answer
7:55 AM-9:30 AM Welcome and General Session 7: Early Onset Colorectal Cancer

Rodrigo Jover, MD, PhD - Chair
Alicante University General Hospital

Andrew T. Chan, MD, MPH - Chair
Massachusetts General Hospital and Harvard Medical School

Shishir Kumar Maithel, MD
Emory University School of Medicine
Welcome of the Day

TBD
Epidemiology of Early Onset Colon Cancer

Fay Kastrinos, MD, MPH
Columbia University Medical Center
Health Disparities, Screening, and Prevention

Irit Ben-Aharon, MD, PhD
Davidoff Cancer Center
Clinical Management and Survivorship Issues

Hold for Potential Abstract

Panel Question and Answer
10:00 AM-11:00 AM Keynote Session: Immunotherapy

TBD
Fundamental Work and Basis for Immunotherapy
11:00 AM-12:30 PM Oral Abstract Session C: Cancers of the Colon, Rectum, and Anus
12:30 PM-2:00 PM Complimentary Boxed Lunch
12:45 PM-1:30 PM Poster Walks
2:00 PM-3:00 PM General Session 8: Controversies in Adjuvant Therapy for Colorectal Cancer (ARS)

TBD - Chair

TBD - Chair

TBD
Duration of Adjuvant Therapy for Colon Cancer—Is 3 Months Enough?

Jeffrey A. Meyerhardt, MD, MPH, FASCO
Dana-Farber Cancer Institute/Partners CancerCare
U.S. Perspective

Timothy Iveson, MD
University Hospital Southampton NHS Foundation Trust
European Perspective

TBD
Role of (Neo)Adjuvant Chemotherapy for Rectal Cancer: U.S. Versus European Approach

Andrea Cercek, MD
Memorial Sloan Kettering Cancer Center
U.S. Perspective

Cornelis J. H. Van De Velde, MD, PhD
Leiden University Medical Center
European Perspective

Panel Question and Answer
3:00 PM-3:15 PM Break
3:15 PM-4:30 PM General Session 9: Contemporary Management of Colorectal Cancer Liver Metastases (ARS)

Flavio G. Rocha, MD - Chair
Virginia Mason Medical Center

Michael J. Hall, MD, MS - Chair
Fox Chase Cancer Center

Case Presentation

Guy A. Van Hazel, FRACP, FRCP, MBBS
Sir Charles Gairdner Hospital
Medical Oncologist Perspective

Alejandra Mendez-Romero
Erasmus Medical Center
Radiation Oncologist Perspective

Mark Hull
University of Leeds
Clinician Scientist Perspective

TBD
Surgeon Perspective